// App-Quantinova.ai

P066 : Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients

Researchers

Presenter

  • Rhea Suribhatla

Principal Investigators

  • Thomas Starkey

  • Maria C Ionescu

  • Lennard Y Lee

Medical Centers

  • Department of Oncology, University of Oxford, Oxford, United Kingdom

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • Medical School, University of Oxford, Oxford, United Kingdom

  • united Kingdom Health Security Agency, UKHSA, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved